Skip to main content

Table 1 Patient characteristics at baseline

From: Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

Characteristics Trastuzumab (T) + paclitaxel (P) (n = 46) Epirubicin (E) + docetaxel (D) (n = 58)
Median age, years 46 46
 Range 23 - 70 27 - 69
Hormone receptor status   
 ER+ and PgR+ 13 33
 ER+ and PgR- 9 9
 ER- and PgR- 21 15
 ER- and PgR+ 3 1
HER2/neu   
  0-1   47
  2+   11
CISH/FISH not amplified / 11
CISH/FISH amplified / /
 3+ 46 /
Stage distribution   
 IIA 6 20
 IIB 27 27
 IIIA 12 10
 IIIB 1 1
Histotype   
 ductal 45 42
 lobular 0 8
 others 1 8
  1. Abbreviations: ER = estrogen receptor; PgR = progesterone receptor; HER2 = human epidermal growth factor receptor-2; CISH = chromogenic in situ hybridization; FISH = fluorescence in situ hybridization.